BioAdaptives Inc (BDPT PINK) stock market data APIs
$0.0027
0(0%)
as of August 18, 2026
Try our APIs with
free plan!
BioAdaptives Inc Financial Data Overview
Price chart is built with
Anychart
BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Prev. Close
0.0027
Open
0.0028
High
0.0029
Low
0.0019
52 wk Range
0.0008-0.07
Market Cap
19 694
Shares Outstanding
12 009 K
Revenue
23 792
EPS
-0.04
Beta
1.295
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BioAdaptives Inc data using free add-ons & libraries
Get BioAdaptives Inc Fundamental Data
BioAdaptives Inc Fundamental data includes:
- Net Revenue: 23 792
- EBITDA: -986 228
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioAdaptives Inc News
New
BioAdaptives Opens Commercial Orders for XcellaraHeart Following Convertible Debt Retirement
Researcher with pipette ©National Institutes of Health BioAdaptives (USOTC:BDPT) announced that it will open commercial ordering later this week for its XcellaraHeart™ cellular wellness formula, f...
BioAdaptives Completes Commercial Supply Chain Ahead of MyndSystem and Xcellara Launches
Researcher looking through microscope ©gebakax BioAdaptives says it has completed its manufacturing and logistics preparations as the company moves toward the commercial launch of its MyndSystem and...
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
LAS VEGAS, June 25, 2026 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT), the parent company of MyndSystem™, today announced that its nighttime repair formula, MyndRenew™, has rec...
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
LAS VEGAS, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a science-driven health and wellness company, today announced the official launch of MyndSystem™, a comprehen...
Get BioAdaptives Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
